OWCM
VRTX icon

One Wealth Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

One Wealth Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$833K Buy
1,936
+670
+53% +$312K 0.36% 41
2025
Q4 		$574K Buy
1,266
+268
+27% +$116K 0.24% 56
2025
Q3 		$391K Buy
998
+195
+24% +$81.5K 0.18% 68
2025
Q2 		$357K Buy
803
+21
+3% +$9.68K 0.17% 70
2025
Q1 		$379K Buy
782
+160
+26% +$74.6K 0.2% 64
2024
Q4 		$250K Buy
+622
New +$288K 0.13% 87

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

One Wealth Capital Management's VRTX Position: Q1 2026 in Review

One Wealth Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 53% in Q1 2026, buying an estimated $312K and bringing the position to 1,936 shares worth $833K. The position accounts for 0.36% of the portfolio, ranked #41.

One Wealth Capital Management first reported a position in VRTX in Q4 2024 and has held it in 6 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • One Wealth Capital Management held 1,936 shares of Vertex Pharmaceuticals worth $833K as of Q1 2026.
  • One Wealth Capital Management bought 670 Vertex Pharmaceuticals shares in Q1 2026, an estimated $312K.
  • Vertex Pharmaceuticals made up 0.36% of One Wealth Capital Management's portfolio in Q1 2026, its #41 holding.
  • One Wealth Capital Management first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on One Wealth Capital Management's 13F filing for Q1 2026, filed 4 May 2026.